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Abstract
Alterations in vitamin D homeostasis, mainly involving its nuclear receptor (VDR), could have a role in the pathophysiology
of the spine. The association between VDR polymorphisms and spine disorders has been analyzed in different ethnic
groups, focusing on the functional FokI polymorphism. However, so far, inconsistent findings were reported. The aims of
this study were to evaluate, in the Italian white population, the VDR FokI polymorphism frequencies distribution in subjects
with clearly defined lumbar spinal pathologies compared to asymptomatic controls and to analyze the interplay of genetic
and conventional risk factors. Using a case-control design, 267 patients with spinal disorders and 220 asymptomatic controls
were enrolled, evaluating their exposition to putative risk factors. Patients’ clinical assessment was performed by Magnetic
Resonance Imaging. FokI polymorphism (rs2228570) was detected by PCR-RFLP. Genotypes were designated by a lowercase
letter (f allele, T nucleotide) for the presence of the restriction site and by a capital letter (F allele, C nucleotide) for its
absence. Family history, higher age and BMI, exposure to vibration, physical job demand, smoking habit and lower practice
of leisure physical activity were associated with spinal disorders. The FF genotype and F allele represented approximately 2-
fold risk factors to develop discopathies and/or osteochondrosis concomitant with disc herniation, while f allele was
protective. In conclusion, the link we observed between VDR FokI variants and specific lumbar spine pathologies suggests
that spinal tissue degeneration is influenced by the genetic background. Future studies should evaluate the signaling
pathways involving alterations in VDR and influencing the development and/or progression of spine disorders.
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Introduction
Low back disorders, in particular disc herniation, which
represents by far the most prevalent pathology causing pain and
sciatica, constitute an important source of disability and one of the
most cost-intensive health problems [1]. In Western countries they
represent the most common musculoskeletal diseases; it is
estimated that 15–20% of adults experience back pain during a
single year and around 50–80% have at least one episode during
their lifetime [2].
Lumbar disc degeneration (LDD) is considered a primary cause
of low back pain (LBP) [3,4]. Many environmental and behavioral
risk factors, including age, gender, weight, occupational load,
smoking and exposure to vehicular vibration are likely to
contribute to the genesis or to the progression of spinal
degeneration and pain onset [5,6,7,8,9,10]. In particular, occupa-
tional exposures to heavy physical loads, prolonged sitting or non-
neutral work postures and vehicle driving have been involved in
the disc degeneration processes [11] and considered as the primary
source of the mechanical factors damaging the spine [12].
However, some epidemiologic studies and reports among families
and twins highlighted that disc herniation, and particularly
sciatica, may be explained to a large degree by hereditary factors
with apparently a relatively minor effects of environmental and
behavioral risk factors [13,14,15,16]. These findings supported the
idea that there is a familiar predisposition for development of disc
degeneration disorders and that such pathologic conditions may
be, at least in part, genetically determined [14,17,18,19,20,21,
22,23].
Vitamin D receptor gene (VDR) has been studied as genetic
factor putatively predisposing to spine pathologies since 1998
[24,25]. Several single nucleotide polymorphisms (SNPs) have
been identified in the VDR sequence, between them FokI
(rs10735810, merged into rs2228570) represents an independent
polymorphic site [26]. It is a C/T transition polymorphic site
located in the VDR start codon, affecting the structure and the
function of the encoded protein. The allelic variants of this
polymorphism code for structurally different receptor proteins
from a 424 aminoacids wild-type (F allele, C) to a 427 aminoacids
long protein (f allele, T). The short and long protein forms are
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associated to a different ability to induce transcription of vitamin
D-dependent genes [27,28,29]. Consequently, studies concerning
the possible association of this SNP with disc degeneration may be
particularly interesting for their potential biological significance.
Wide evidences support the notion that the vitamin D endocrine
system is involved in the modulation of different biological
processes, including skeletal metabolism, immunological response,
proliferation and differentiation of a wide variety of cell types
[30,31]. More recently some studies detected the presence of VDR
also in the disc cells, highlighting the prominent role of vitamin D
active metabolites in the regulation of cells proliferation, matrix
genes expression and specific cytokines and proteins production
[32,33].
The pleiotropic effects of vitamin D and its involvement in bony
and disc metabolisms could explain why alterations in vitamin D
homeostasis could be associated to several pathological conditions
of the intervertebral disc (IVD).
The association of FokI polymorphism in VDR with hernia, disc
degeneration [25,34,35,36] or lumbar spinal stenosis [37] and with
occupational vibration, leading to the development of LDD
[38,39], was analyzed in different ethnic groups. However, so far
inconsistent findings were reported [40]. This can derive, at least
in part, from the lack of a clear definition of the lumbar spine
pathological phenotypes and/or by the poor definition or
differences associated to the specific ethnic group examined.
To our knowledge, there are no studies investigating the
association of FokI polymorphism in VDR and specific lumbar
spine pathologies in the Italian white population.
Based on these evidences, the aims of this study were:
i. to evaluate the VDR FokI alleles frequencies distribution in
subjects with specific lumbar spine pathologies in comparison
with asymptomatic controls in the Italian population;
ii. to analyze the interplay of genetic and conventional,
behavioral and environmental factors in the development of
lumbar spine pathologies.
Materials and Methods
Ethics Statement
The study was approved by the Institutional Review Board ASL
Citta` di Milano. The methods used in this study were in
accordance with the Helsinki Declaration of 1975 as revised in
1996.
Subjects
Using a case-control design, a total of 487 Italian white subjects,
age range 18–65 years, were enrolled after having signed a written
informed consent. Inclusion criteria for cases were the presence of
a lumbar spine pathology confirmed by Magnetic Resonance
Imaging (MRI), while inclusion criteria for controls were the
absence of LBP or confirmed severe or chronic spine pathologies.
The concomitant presence of other orthopedic diseases such as
osteoarthrosis, hip, knee and hand osteoarthritis, osteoporosis was
recorded.
Exclusion criteria for both cases and controls were presence of a
pathologic condition such as cervical discopathies, scoliosis,
fibromyalgia, pregnancy at study enrollment, and chronic diseases
like diabetes, cardiovascular diseases, malignancies, lupus erythe-
matosus, and rheumatoid arthritis.
The study included 267 consecutive patients (hospitalized or
outpatients) with lumbar spine disorders enrolled for the European
Genodisc Project, from May 2009 to January 2013, at the
Orthopedics and Traumatology Department of I.R.C.C.S. Istituto
Ortopedico Galeazzi (Milan, Italy) by the same clinician. A total of
220 asymptomatic controls were enrolled from January 2011 to
January 2013 among healthy volunteers, blood donors or subjects
hospitalized for anterior cruciate ligament injuries or hallux valgus
surgery.
Clinical Assessment
Assessment of lumbar spine disorders was performed by an
expert clinician in spinal diseases by contrast-enhanced MRI 12
scans of the lumbar spine with a 1.5 T scanner (Avanto, Siemens,
Erlangen, Germany). Diagnosis of disc herniation was performed
when patients presented disc material protrusion/extrusion
beyond the posterior margins of the adjacent vertebral bodies
[41] (Figure 1a). Disc herniations were often associated with
discopathies and/or osteochondrosis (Figure 1b). Diagnosis of
discopathies was performed in presence of degenerative changes of
the IVD, while diagnosis of osteochondrosis was performed in
presence of degenerative process involving primarily the vertebral
bodies structures limiting the disc (disc narrowing, subchondral
sclerosis, wavy endplates, osteophytes and Schmorl’s node) [42]
(Figure 1c). Spinal stenosis was diagnosed in presence of a
narrowing of the central spinal canal, lateral recess or interver-
tebral foramina [43,44] (Figure 1d). Finally, patients with
degenerative spondylolisthesis presented an acquired anterior
displacement of a vertebra over the subjacent one (Figure 1e),
due to degenerative changes, without an associated disruption or
lysis of the pars interarticularis [45], that is present in patients with
lytic/isthmic spondylolisthesis [44]. Stenosis and spondylolisthesis,
which are the more concerning structural degenerative spine
changes, were often associated (Figure 1f).
Based on these diagnosis, patients were classified in 4 different
mutually exclusive subgroups. Subgroup 1 comprised disc
herniation only patients (n = 89); Subgroup 2 comprised patients
with discopathies (n = 46), osteochondrosis (n = 37) or both (n= 4)
associated with disc herniation (total n = 87); Subgroup 3
Figure 1. Patient’s clinical assessment and classification in
subgroups. a) Subgroup 1, patients with disc herniation only. b)
Subgroup 2, patients with discopathies and/or osteochondrosis
associated with disc herniation. c) Subgroup 3, patients with
discopathies and/or osteochondrosis, without disc herniation, d–f)
Subgroup 4, patients with stenosis (d), spondylolisthesis (e) or both (f).
White arrows indicate the characteristic pathological features of each
subgroup.
doi:10.1371/journal.pone.0097027.g001
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comprised patients with discopathies (n = 18), osteochondrosis
(n = 13) or both (n= 9) without herniation (total n = 40); Subgroup
4 comprised patients with stenosis (n = 11), lytic/isthmic spondy-
lolisthesis (n = 20), degenerative spondylolisthesis (n = 10) or
stenosis and lytic/isthmic spondylolisthesis (n = 7), stenosis and
degenerative spondylolisthesis (n = 3) (total n = 51).
Since the close linkage between discopathies, disc herniation
and osteochondrosis, a further subgroups division from A to D (not
mutually exclusive) was performed to better analyze the associa-
tion between these pathologies and VDR FokI genotypes in our
cohort of patients: Subgroup A, comprising all herniation cases i.
e. Subgroup 1 grouped with Subgroup 2 (total n = 176); Subgroup
B, including all discopathies and/or osteochondrosis regardless of
herniation, i.e. Subgroup 2 grouped with Subgroup 3 (total
n = 127); Subgroup C, comprising all discopathies concomitant
with disc herniation (n= 46) grouped with subjects with discop-
athies alone (n = 18) (total n = 64); and Subgroup D, comprising all
osteochondrosis concomitant with disc herniation (n= 37) grouped
with subjects with osteochondrosis alone (n = 13) (total n = 50).
Conventional, Behavioral and Environmental Factors
Evaluation
A medical history, including possible low back symptoms or
spine surgery, and a questionnaire, reporting the exposition to
individual behavioral, environmental, occupational and physical
activity putative risk factors were obtained from each subject. The
collected information included medical history of family (parents,
brothers or sisters), the smoking habit, the job physical demand for
the majority of the working years (evaluated by the following score:
0 = sedentary; 1 = light; 2 =medium; 3= heavy), the hours/day
spent driving or as a passenger in motorized vehicles (exposure to
vibrations) and, finally, over the past year, the times a week
(outside work activity) spent in vigorous physical activity or leisure
exercise activities involving twisting, bending or lifting (indicated
thereafter collectively as leisure physical activity).
Determination of Genotypes
Blood samples were collected from the antecubital vein with
evacuated ethylenediamine tetra acetic acid (EDTA) tubes
(Vacutainer Tubes, Becton-Dickinson, Franklin Lakes, NJ, USA)
from the 267 cases and 220 controls. Genomic DNA was extracted
from white blood cells according to the procedure of the DNeasy
Midi kit (Qiagen, Duesseldorf, Germany). Polymerase chain
reaction and restriction fragment length polymorphism (PCR-
RFLP) methods were applied to detect the FokI polymorphism of
VDR. Genomic DNA was amplified using PCR. At first DNA was
denatured at 95uC for 5 minutes. Standard PCR conditions were
as follows: 94uC for 1 minute, annealing temperature 63uC for
1 minute and 72uC for 2 minutes for 35 cycles and finally 96uC for
1 minute and 72uC for 5 minutes.
The FokI polymorphism of VDR was studied using previously
tested primers [46].
The resulting 265 bp DNA fragment was digested with FokI
restriction enzyme (Euroclone, Milano, Italy) generating two
fragments of 196 and 69 bp only in presence of the f allele (T).
DNA fragments were separated on poliacrylamide gel. Randomly
chosen 30 samples’ gel results were confirmed by DNA
sequencing.
Genotypes were designated by a lowercase letter (f allele, T
nucleotide, mutated) for the presence of the restriction site and by
a capital letter (F allele, C nucleotide, wild-type) for its absence
(Figure 2).
Statistical Analysis
Kolmogorov-Smirnov test was used to assess the normal data
distribution. Student’s t-test or Mann Whitney test were used to
assess the differences between the frequency distributions of
variables in cases and controls. Odds ratios (ORs) were calculated
to set the association between alleles or genotypes and risk of spine
pathologies in cases and controls and specific Subgroups of
patients. Chi squared or Fisher’s exact test P values were reported
as appropriate. Logistic regression was used to evaluate effects of
confounders by obtaining adjusted ORs and 95% CIs for
genotypes and alleles. Adjusted analysis included conventional
risk factors: age, BMI, family history, smoke, physical job demand
and exposure to vibrations. Leisure physical activity was not
included as confounding because this kind of activity may derive
both by personal habits and by absence of pain.
Significance level was held at 0.05. At variance, P values #0.10
were considered as a tendency. Statistical softwares used were
GraphPad Prism version 5.00 (GraphPad software, La Jolla, CA,
USA) and SPSS version 14.0 (SPSS Inc., Chicago, IL, USA).
Results
Characteristics of Subjects
The characteristics of the overall population of cases and
controls, including age, gender, BMI, spine surgery, family history,
smoking habit, job physical demand, exposure to vibrations,
practice of leisure physical activity and presence of other
orthopedic conditions were shown in Table 1. Among the cases,
there were more males (149/267, 55.8%) than females (118/267,
44.2%), while among controls there were almost equal numbers of
males (106/220, 48.2%) and females (114/220, 51.8%). Due to the
study design, surgery for disc pathologies (39% of cases) and
presence of other orthopedic conditions (12.7% of cases) were
present only in the cohort of cases.
In our group of patients with lumbar spine disorders the more
frequent pathologies were the disc herniation alone (Subgroup 1,
89/267, 33.3%), herniation associated with discopathies and/or
osteochondrosis (Subgroup 2, 87/267, 32.6%), followed by
stenosis and/or spondylolisthesis without herniation (Subgroup
4, 51/267, 19.1%) and by discopathies and/or osteochondrosis
without herniation (Subgroup 3, 40/267, 15.0%). Gender
distribution throughout Subgroups 1 to 4 was similar, with the
exception of Subgroup 2, which included 55 males (63.2% of male
cases) and only 32 females (36.8% of female cases). Family history
of spine pathologies was highest (43.7%) in the Subgroup 2. Spine
surgery frequency was highest in Subgroup 3 (67.5%).
Influences of Conventional, Behavioral and
Environmental Risk Factors
Associations between lumbar spine pathologies and putative
conventional risk factors were reported as continuous variables in
all cases and in mutually exclusive Subgroups 1 to 4 in Table 1. In
the overall cohort of cases higher age (P,0.001), higher BMI
(P= 0.001), family history (OR=3.02; 95%CI= 1.94–4.68; P,
0.001), smoking habit (OR=1.54; 95%CI=1.08–2.21; P = 0.020),
stronger job physical demand (P = 0.001), higher exposure to
vibration (P= 0.013) were all significantly associated with the
development of lumbar spine pathologies. Controls subjects
practiced leisure physical activity more frequently than the
pathological subjects (OR=2.33; 95%CI= 1.61–3.37; P,0.001).
By analyzing the specific subgroups (from 1 to 4) of cases in
comparison with controls, an influence of higher age was
evidenced for Subgroup 1 (P= 0.048), Subgroup 2 (P= 0.003)
and Subgroup 4 (P,0.001), with a tendency for Subgroup 3
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(P = 0.093). An influence of higher BMI was observed only for
Subgroup 2 (P= 0.005) and Subgroup 4 (P,0.001). Although not
significant, a tendency for an association between male gender and
spine pathologies was observed (OR=1.36; 95%CI= 0.95–1.94;
P = 0.094). However, male gender was significantly associated with
spine pathologies only in Subgroup 2 (OR=1.85; 95%CI= 1.11–
3.08; P = 0.018).
The association of spine pathologies with family history was
observed in Subgroup 1 (OR=3.11; 95%CI= 1.78–5.46; P,
0.001), Subgroup 2 (OR=4.10; 95%CI= 2.35–7.15; P,0.001)
and Subgroup 4 (OR=2.20; 95%CI= 1.09–4.44; P = 0.028), with
a tendency for Subgroup 3 (OR=2.00; 95%CI= 0.92–4.38;
P = 0.081).
Concerning the smoking habit a higher frequency of subjects
exposed to this risk factor was registered in pathological Subgroups
1 (OR=2.05; 95%CI=1.24–3.38; P= 0.005) and Subgroup 2
(OR=1.88; 95%CI= 1.14–3.11; P= 0.014) in comparison with
controls.
A stronger job physical demand was observed in Subgroup 1
(P = 0.009) and Subgroup 2 (P = 0.023), with a tendency for
Subgroup 3 (P= 0.064) and Subgroup 4 (P= 0.091). Finally, a
higher exposure to vibrations was registered in Subgroup 2
(P = 0.001) in respect to controls.
Controls subjects practiced leisure physical activity more
frequently than the subjects in Subgroup 1 (OR=1.82;
95%CI= 1.10–3.03; P= 0.020), Subgroup 2 (OR=2.72;
95%CI= 1.59–4.64; P,0.001), Subgroup 3 (OR=2.27;
95%CI= 1.12–4.64; P= 0.024) and Subgroup 4 (OR=2.89;
95%CI= 1.48–5.65; P = 0.002).
VDR Genotypes and Alleles in Controls and Cases
In our total sample of 487 Italian white subjects the frequency of
FF homozigotes was 42.3% (206/487), Ff heterozigotes was 46.9%
(219/487) and ff homozigotes was 12.9% (62/487). F allele had a
frequency of 64.8% (631/974) and the f allele had a frequency of
35.2% (343/974). The observed genotype frequencies were
consistent with Hardy-Weinberg equilibrium (X2= 0.102,
P= 0.75).
Table 2 reported frequencies of FokI genotypes and alleles in
cases and controls, including crude and adjusted ORs and
95%CIs. Not significant differences in the frequencies distribution
of both genotypes and alleles were observed in overall subjects, the
wild homozygous FF genotype was present in 43.8% of cases
versus 40.5% of controls, while the minor ff homozygous genotype
was found in 14.5% controls versus 11.2% of cases, and the
heterozygous Ff genotype had the same frequency between cases
and controls (45.0%). F allele had a frequency of 66.3% in cases
versus 63.0% of controls, while f allele had a frequency of 37.0% in
controls versus 33.7% of cases. Neither controls (X2 = 0.273,
P= 0.60) nor cases (X2 = 0.0085, P= 0.93) deviated from Hardy-
Weinberg equilibrium.
Association of Specific Lumbar Spine Pathologies and
VDR Genotypes and Alleles
The frequencies distribution of FokI VDR genotypes and alleles
in different specific pathological subgroups (1–4 and A–D) and in
controls subjects, with the relative crude and adjusted ORs and
95%CIs, were reported in Tables 3 and 4, respectively.
Concerning genotypes (Table 3), the only significant association
Figure 2. Structure of the genomic region of the VDR and location of the FokI polymorphism (a). The VDR is located on chromosome 12
and contains nine exons: number 1, designated 1f–1c and indicated with white bars, contains six untranslated subunits in the promotor region, while
the other eight exons, numbers 2–9, indicated with black bars in the coding region, encode proteins. FokI polymorphism is located in the exon 2, it is
a C.T point mutation, the FokI enzyme cleaves when the restriction site ATG, a start codon, is present. A representative gel for the determination of
FokI genotypes in three patients is showed (b). In the first lane there is a molecular weight DNA ladder (M) for size estimation of the DNA fragments.
The letter ‘‘A’’ in the second, fourth and sixth lanes indicates the 265 bp PCR amplicons of the three patients. After digestion of the PCR product with
FokI restriction enzyme an undigested 265 bp fragment (third lane, homozygous genotype FF, CC nucleotides), partially digested 265, 196 and 69 bp
fragments (fifth lane, heterozygous genotype Ff, CT nucleotides), or totally digested 196 and 69 bp fragments (seventh lane, homozygous genotype
ff, TT nucleotides) are present for the first, second and third patient, respectively.
doi:10.1371/journal.pone.0097027.g002
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was found between the wild homozygous FF genotype and the
presence of discopathies and/or osteochondrosis concomitant with
disc herniation (Subgroup 2) (crude OR=1.90; 95%CI= 1.15–
3.13; P= 0.012; adjusted OR=2.09; 95%CI= 1.17–3.72;
P = 0.012). In the same patients (Subgroup 2) the ff genotype
tended to be protective (crude OR=0.43; 95%CI= 0.17–1.08;
P = 0.073), but P became .0.10 after the OR adjustment for
conventional risk factors.
In subjects with discopathies and/or osteochondrosis without
herniation (Subgroup 3) the Ff genotype showed a tendency to be
a risk factor (adjusted OR=2.00; 95%CI= 0.96–4.16; P= 0.063)
and the ff genotype had a tendency to be protective (adjusted
OR=0.30; 95%CI= 0.07–1.24; P= 0.096). No other significant
finding was observed even grouping Subgroups 1, 2 and 3
altogether (thus excluding the Subgroup 4).
To further explore possible associations of FokI polymorphisms
with specific subsets of patients we grouped in Subgroup A all
patients with hernia (with or without concomitant additional
conditions), however, no significant genotype differences were
evidenced. In Subgroup B we included all patients with
discopathies and/or osteochondrosis regardless of hernia presence
(Subgroups 2 plus 3), for this subgroup we observed a protective
role of the ff genotype (crude OR=0.45; 95%CI= 0.21–0.97;
P = 0.042, and adjusted OR=0.38; 95%CI= 0.15–0.94;
P = 0.037). A similar protective association of the ff genotype
was observed for all patients having osteochondrosis (Subgroup D),
(crude OR=0.24; 95%CI=0.06–1.06; P= 0.059, and adjusted
OR=0.17; 95%CI=0.03–0.97; P= 0.046). Finally, by grouping
all patients having discopathies (Subgroup C) a 2-fold association
was found for the FF genotype both in crude and adjusted analyses
(crude OR=2.02; 95%CI=1.15–3.55; P= 0.015, and adjusted
OR=1.85; 95%CI= 1.00–3.42; P= 0.049).
The alleles distribution (Table 4) showed a higher frequency of
the wild F allele in Subgroup 2 i.e. patients having discopathies
and/or osteochondrosis concomitant with disc herniation (crude
OR=1.74; 95%CI= 1.17–2.57; P= 0.005; adjusted OR=1.80;
95%CI= 1.15–2.82; P= 0.011). Consequently, the mutated f allele
was protective for these pathological features. The F allele was
risky for Subgroup B (discopathies and/or osteochondrosis) crude
OR=1.46; 95%CI= 1.04–2.04; P= 0.026; adjusted OR=1.50;
95%CI= 1.04–2.18; P= 0.031; and Subgroup C (discopathies in
general) crude OR=1.76; 95%CI= 1.13–2.75; P= 0.012; adjust-
ed OR=1.62; 95%CI=1.00–2.62; P= 0.049. Consequently the f
allele was protective for patients of Subgroups B and C (as
reported in Table 4).
Discussion
To our knowledge, this is the first study that evaluated and
showed an association between VDR FokI variants and specific
spine pathologies in the Italian white population and the largest
study showing also the concomitant influences of conventional risk
factors.
In our study we determined FokI genotypes and alleles
frequencies in a sample of 487 Italian white subjects enrolled in
Milan (Northern Italy). Our frequencies were very close to those
reported in an other study performed in 102 Italian subjects from
Tuscany (Central Italy) (FF=42.2%, Ff=42.2%, ff=15.7%;
F=63.2%, f=36.8%) [47]. In general, we observed similar
frequencies distribution of FokI genotypes and alleles between
our cohort of Italian subjects and European subjects, in particular
Finnish twins (n = 85 pairs, FF=28%, Ff=58%, ff=14%;
F=60%, f=40%) [25], 56 Finnish controls (FF=44.6%,
Ff=46.4%, ff=8.9%; F=67.9%, f=32.1%) [37], 150 Turkish
healthy subjects (F=67%, f=33%) [34] and German healthy
women (n= 2596, FF=38.5%, Ff=46.3%, ff=15.2%; F=62%,
f=38%) [48].
Moreover, we observed that the VDR FokI polymorphism in our
Italian sample was in Hardy-Weinberg equilibrium as previously
found in other European populations [25].
The association between the presence of polymorphisms in the
VDR and lumbar spine pathologies is a debated topic [24]. In our
study, considering the very broad category of patients with lumbar
spine disorders, the FokI polymorphism was not associated with
disease risk. However, this polymorphism represented a risk factor
to develop discopathies in general, and particularly discopathies
and/or osteochondrosis concomitant with disc herniation.
Three previous studies from other authors reported an
association between the FokI polymorphism in VDR and specific
signs of disc degeneration in Turkish [34], Brazilian [35] and
Finnish [25] populations, with subjects having Ff and ff genotypes
showing a predisposition towards worse phenotypes.
By contrast, other studies found no association between FokI
genotypes and disc pathologies. Specifically, no association was
observed for disc herniation or lumbar spinal stenosis in the
Finnish population [25,37]; nor for LDD in a Norway case/
control study [36] and neither for osteophyte formation without
disc degeneration in a cohort of elderly Japanese males and
females with LBP [49].
The comparison of data present in the literature is particularly
difficult especially because of the study design and ethnic
differences in the various research studies. Moreover, the absence
of a standardized definition of pathological phenotypes hampers
the comparisons and reliable interpretations of the reported data.
In our work, we classified our cases by means of the pathological
features evidenced throughout detailed objective evaluation by
MRI. This approach allowed us to subgroup patients accordingly
to specific lumbar spine pathologies having a defined clinical
significance. To evaluate the association of VDR FokI genotypes/
alleles, we first analyzed the broad sample of all patients with
Table 2. VDR FokI genotypes and alleles in controls and cases.
Variables Controls n=220 (%) Cases n=267 (%) Crude OR (95% CI) Adjusted OR1 (95% CI)
VDR-FokI genotypes FF 89 (40.5) 117 (43.8) 1.15 (0.80–1.65) 1.10 (0.74–1.63)
Ff 99 (45.0) 120 (45.0) 1.00 (0.70–1.43) 0.98 (0.66–1.45)
ff 32 (14.5) 30 (11.2) 0.74 (0.44–1.27) 0.86 (0.48–1.55)
VDR-FokI alleles F 277/440 (63.0) 354/534 (66.3) 1.16 (0.89–1.51) 1.09 (0.82–1.45)
f 163/440 (37.0) 180/534 (33.7) 0.86 (0.66–1.12) 0.92 (0.69–1.23)
1Adjusted OR: multivariate analysis, OR adjusted for age, BMI, family history, smoke, physical job demand and exposure to vibrations.
doi:10.1371/journal.pone.0097027.t002
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lumbar spine disorders, then we subgrouped them in 4 mutually
exclusive subgroups (1 to 4). Moreover, we analyzed subgroups of
all patients having a condition in common like hernia, discopathy,
osteochondrosis, regardless of other concomitant disorders (Sub-
groups A to D).
Considering specific subgroup of patients i.e. those suffering
from discopathies and/or osteochondrosis concomitant with
herniation, and in general all patients having discopathies, the
FF genotype was associated with a 2-fold increased disease risk,
also after adjusting for conventional, behavioral and environmen-
tal risk factors. The F allele was associated with a 1.5 to 1.8-fold
increased risk in all patients having discopathies, in all patients
having osteochondrosis, and in patients having discopathies and/
or osteochondrosis concomitant with herniation. On the contrary,
f allele seemed to be protective for these pathological phenotypes.
We confirmed these results after adjusting for conventional risk
factors.
In general, genetic risk factors may interact with behavioral and
environmental factors in enhancing the development of lumbar
spine pathologies. In this context, the results present in the
literature about a possible interplay between VDR FokI genotypes,
occupational load exposure and exposition to whole-body
vibration were controversial [38,39].
In our study, regarding environmental risk factors such as
exposure to vibrations and job physical effort, we observed an
association between lumbar spine pathologies, higher number of
hours/day exposure to vibration and higher physical job demand.
On the contrary, we noted that the practice of leisure physical
activity was inversely associated to lumbar spine pathologies. Due
to the study design, we cannot assess if this was a really protective
behavior or an indication of absence of major low back pain,
concomitant with personal habits. Among the other putative
conventional risk factors analyzed, we observed that in our cohort
of cases family history, higher age, overweight and smoking habit
were associated with risk for lumbar spine pathologies. Overall,
our findings highlighted that subject voluntary behaviors in
addition to environmental factors are major determinants in
lumbar spine pathologies.
A limitation of this study is represented by the difference in the
mean age of the recruited cases and controls. We found difficulties
in finding over 50 years old healthy subjects and, thus, in the
future we would like to enlarge the group of controls, trying to
match this difference and to confirm our results in a larger cohort
of subjects.
Additionally, an increase in the number subjects with stenosis
and/or spondylolisthesis (Subgroup 4), could be useful to perform
a better evaluation of particular features of this subgroup.
In conclusion, the conventional, behavioral and environmental
factors analyzed in this study represented determinants of risk for
the development of lumbar spine pathologies in general. On the
contrary, finding of genetic associations required objective
characterization of lumbar spine disorders. Particularly, we
evidenced that personalized evaluation through imaging tech-
niques of each patient is necessary to determine the appropriate
subgroup belonging. Our results showed that patients with FF
homozygous genotype are at risk to develop discopathies in
general and discopathies and osteochondrosis in association with
disc herniation, independently by the influence of the conventional
behavioral and environmental determinants of risk. It is of note
that in our study the FF homozigosity was not a risk factor for
simple herniation. Notably, the F allele was an independent risk
factor for all discopathies, discopathies and osteochondrosis,
discopathies and osteochondrosis combined with herniation, but
not simple herniation, stenosis and spondylolisthesis. Additionally,
in an adjusted analysis the F allele was a 1.7-fold risk factor for
osteochondrosis.
Based on the assumption that the wild F allele is producing a
more transcriptionally active receptor than the f allele, it appears
that enhanced vitamin D final effects are favoring discopathies and
the severe progression of discopathy and/or osteochondrosis to
herniation. Interestingly, a very recent study performed in 140
Iranian subjects with diabetes evidenced that the VDR ff genotype
may be regarded as ‘‘low responders’’ to vitamin D intake [50].
Table 4. Association of lumbar spine pathologies and VDR FokI alleles.
F Crude OR Adjusted OR1 f Crude OR Adjusted OR1
n (%) (95% CI) (95% CI) n (%) (95% CI) (95% CI)
P value P value P value P value
Controls n = 440 277 (63.0) 163 (37.0)
Subgroup 1 n = 178 114 (64.0) 1.05 (0.73–1.51) 0.95 (0.64–1.41) 64 (36.0) 0.95 (0.66–1.37) 1.06 (0.71–1.57)
Subgroup 2 n = 174 130 (74.7) 1.74 (1.17–2.57) P = 0.005 1.80 (1.15–2.82) P = 0.011 44 (25.3) 0.57 (0.39–0.85) P = 0.005 0.56 (0.35–0.87) P = 0.011
Subgroup 3 n = 80 51 (63.8) 1.03 (0.63–1.70) 1.07 (0.64–1.81) 29 (36.2) 0.97 (0.59–1.59) 0.93 (0.55–1.57)
Subgroup 4 n = 102 59 (57.8) 0.81 (0.52–1.25) 0.65 (0.40–1.07) 43 (42.2) 1.24 (0.80–1.92) 1.53 (0.94–2.49)
Subgroup 1+2+3 n = 432 295 (68.3) 1.27 (0.96–1.68) 1.22 (0.90–1.66) 137 (31.7) 0.79 (0.60–1.04) 0.82 (0.60–1.11)
Subgroup A n=352 244 (69.3) 1.33 (0.99–1.79) 1.25 (0.90–1.74) 108 (30.7) 0.75 (0.56–1.01) 0.80 (0.57–1.11)
Subgroup B n = 254 181 (71.3) 1.46 (1.04–2.04) P = 0.026 1.50 (1.04–2.18) P = 0.031 73 (28.7) 0.68 (0.49–0.96) P = 0.026 0.66 (0.46–0.96) P = 0.031
Subgroup C n= 128 96 (75.0) 1.76 (1.13–2.75) P = 0.012 1.62 (1.00–2.62) P = 0.049 32 (25.0) 0.57 (0.36–0.88) P = 0.012 0.62 (0.38–1.00) P = 0.049
Subgroup D n= 100 72 (72.0) 1.51 (0.94–2.44) 1.72 (1.00–2.95) P = 0.051 28 (28.0) 0.66 (0.41–1.06) 0.58 (0.34–1.00) P = 0.051
Subgroup 1 =patients with disc herniation alone; Subgroup 2= patients with discopathies and/or osteochondrosis associated with disc herniation; Subgroup
3= patients with discopathies and/or osteochondrosis without herniation; Subgroup 4 =patients with stenosis and/or spondylolisthesis. Subgroup A, Subgroup 1
grouped with Subgroup 2 (i.e. all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2 grouped with Subgroup 3; Subgroup C, all
discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis cases with or without concomitant disc herniation.
1Adjusted OR: multivariate analysis, OR adjusted for age, BMI, family history, smoke, physical job demand and exposure to vibrations.
Only significant P#0.05 were indicated.
doi:10.1371/journal.pone.0097027.t004
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Thus, it is tempting to speculate that a nutrigenic approach
based on specific genotypes may be needed to protect patients with
specific lumbar spine disorders.
Finally, the lack of significant finding for the association of
simple herniation with the genetic background could reflect the
accidental/traumatic origin of this condition and/or the necessity
to explore different genetic polymorphisms for this specific
disorder.
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